Press Releases

All Releases
View Summary Arbutus to Present TKM-HBV Data at the 2015 AASLD Liver Meeting
Oct 1, 2015
PDF 12.2 KB Add to Briefcase
View Summary Arbutus to Present at the Baird 2015 Healthcare Conference
Sep 9, 2015
PDF 8.8 KB Add to Briefcase
View Summary Arbutus Announces Initiation of Patient Dosing in the TKM-PLK1 HCC Expansion Cohort
Aug 25, 2015
PDF 13.0 KB Add to Briefcase
View Summary Arbutus to Present at 2015 Wedbush PacGrow Healthcare Conference
Aug 7, 2015
PDF 8.8 KB Add to Briefcase
View Summary Arbutus Announces Second Quarter 2015 Financial Results
Aug 5, 2015
PDF 24.2 KB Add to Briefcase
View Summary Arbutus to Present at Jefferies Hepatitis B Summit
Aug 3, 2015
PDF 8.8 KB Add to Briefcase
View Summary Arbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals
Aug 3, 2015
PDF 10.4 KB Add to Briefcase
View Summary Tekmira Announces Launch of Arbutus Biopharma, a Hepatitis B Solutions Company
Jul 20, 2015
PDF 17.2 KB Add to Briefcase
View Summary Tekmira Provides Update on TKM-Ebola-Guinea
Jun 19, 2015
PDF 17.3 KB Add to Briefcase
View Summary Tekmira to Present at JMP Securities Life Sciences Conference
Jun 18, 2015
PDF 10.3 KB Add to Briefcase
View Summary Tekmira to Present at Jefferies 2015 Healthcare Conference
May 21, 2015
PDF 10.3 KB Add to Briefcase
View Summary Tekmira Provides Corporate Update and Announces First Quarter 2015 Results
May 6, 2015
PDF 29.4 KB Add to Briefcase
View Summary Tekmira to Present at Deutsche Bank Health Care Conference
May 1, 2015
PDF 10.4 KB Add to Briefcase
View Summary Tekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results
Apr 22, 2015
PDF 10.5 KB Add to Briefcase
View Summary Tekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal
Apr 22, 2015
PDF 17.3 KB Add to Briefcase
View Summary FDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers
Apr 10, 2015
PDF 16.3 KB Add to Briefcase
View Summary Tekmira Presents Preclinical Results Demonstrating Super-Additive Effects on Plasma Triglyceride Lowering by Silencing of ApoC3 and ANGPTL3 Genes
Mar 25, 2015
PDF 18.2 KB Add to Briefcase
View Summary Tekmira Announces Completion of Underwritten Public Offering of Common Shares
Mar 25, 2015
PDF 14.3 KB Add to Briefcase
View Summary Tekmira Announces Pricing of Underwritten Public Offering of Common Shares
Mar 20, 2015
PDF 14.7 KB Add to Briefcase
View Summary Tekmira Announces Proposed Public Offering of Common Shares
Mar 18, 2015
PDF 106.7 KB Add to Briefcase
Showing 41-60 of 323 Page: 1 2 3 4 5 6 7 ... 17  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase